MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.510
+0.010 (0.22%)
At close: Mar 9, 2026, 4:00 PM EDT
4.510
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
MiMedx Group Employees
MiMedx Group had 808 employees as of December 31, 2025. The number of employees decreased by 29 or -3.46% compared to the previous year.
Employees
808
Change (1Y)
-29
Growth (1Y)
-3.46%
Revenue / Employee
$518,106
Profits / Employee
$60,121
Market Cap
670.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 579 |
| Replimune Group | 479 |
| Prime Medicine | 214 |
| ProKidney | 204 |
| Vor Biopharma | 154 |
| Theravance Biopharma | 97 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
MDXG News
- 4 days ago - MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields - GlobeNewsWire
- 11 days ago - MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - GlobeNewsWire
- 20 days ago - MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 - GlobeNewsWire
- 4 weeks ago - MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products - GlobeNewsWire
- 5 weeks ago - MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX® - GlobeNewsWire
- 2 months ago - MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - GlobeNewsWire
- 4 months ago - MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial - GlobeNewsWire